Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Pritelivir

Generic Name: Pritelivir

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₁₈N_₄O_₃S_₂

CAS Number: 348086-71-5

Unique Ingredient Identifier: 07HQ1TJ4JE

Overview

Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.

Background

Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2

Posted: 2023/05/06

Sponsor:AiCuris Anti-infecti...

ID:NCT05844436

Thorough QT/QTc of Pritelivir in Healthy Subjects

Phase 1

Completed

Posted: 2023/01/04

Sponsor:AiCuris Anti-infecti...

ID:NCT05671029

Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir

Phase 1

Completed

Posted: 2022/08/24

Sponsor:AiCuris Anti-infecti...

ID:NCT05513625

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Phase 3

Recruiting

Posted: 2017/03/08

Sponsor:AiCuris Anti-infecti...

ID:NCT03073967

Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes

Phase 2

Completed

Posted: 2016/08/18

Sponsor:AiCuris Anti-infecti...

ID:NCT02871492

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy